Certainly! Here is a comprehensive, up-to-date answer based on the latest available information and your requirements.
1. Summary:
Sepsis research and drug development are funded by a mix of government agencies, philanthropic organizations, and international consortia. The largest funders are in the US, UK, EU, and Asia, with additional support from global health alliances and private foundations. Funding covers basic research, clinical trials, diagnostics, therapeutics, and epidemiology. Below is a detailed breakdown of the main agencies, current funding opportunities, and open calls as of May 2025, with sources provided for each.
2. Funding Agencies:
United States
- National Institutes of Health (NIH): The primary US government funder for biomedical research, including sepsis. Key institutes include NIGMS (National Institute of General Medical Sciences) and NIAID (National Institute of Allergy and Infectious Diseases).
- Agency for Healthcare Research and Quality (AHRQ): Funds health services research, including sepsis epidemiology and outcomes.
- Biomedical Advanced Research and Development Authority (BARDA): Supports advanced development of medical countermeasures, including sepsis diagnostics and therapeutics.
- Centers for Disease Control and Prevention (CDC): Funds research and public health initiatives related to sepsis prevention and management.
- Congressionally Directed Medical Research Programs (CDMRP): Funds military and civilian medical research, including infectious diseases and sepsis.
United Kingdom
- Medical Research Council (MRC): Major UK government funder for biomedical research, including sepsis.
- Sepsis Research FEAT: The only UK charity dedicated to funding sepsis research.
European Union
- Horizon Europe: The EU’s main research and innovation funding program, supporting large consortia and clinical trials for sepsis and related conditions.
Global/Philanthropic
- Global Sepsis Alliance (GSA): Coordinates international advocacy and research priorities for sepsis.
- Global Antibiotic Research and Development Partnership (GARDP): Funds global research and clinical trials for new antibiotics and sepsis treatments, especially for neonates.
- Bill & Melinda Gates Foundation: Funds global health research, including sepsis and antimicrobial resistance.
- Wellcome Trust: Major UK-based philanthropic funder of infectious disease research, including sepsis and AMR.
Asia
- National Natural Science Foundation of China (NSFC): Major funder of sepsis research in China.
- Indian Council of Medical Research (ICMR): India’s main biomedical research funder, supporting infectious disease and sepsis research.
3. Funding Opportunities (as of May 2025):
United States
- NIH R01, R21, R33, SBIR/STTR Grants: Multiple open calls for sepsis research, including basic, translational, and clinical studies, as well as small business innovation.
- AHRQ Large Research Grants (R01) and Demonstration Projects (R18): Up to $500,000/year for up to 5 years for health services research on sepsis.
- BARDA DRIVe: Open calls for diagnostics, therapeutics, and digital health solutions for sepsis.
United Kingdom
- Sepsis Research FEAT Grants: Open calls for UK-based sepsis research projects.
- MRC and NIHR: Regular calls for infectious disease and critical care research, including sepsis.
European Union
- Horizon Europe: Calls for collaborative research on infectious diseases, AMR, and sepsis.
Global/Philanthropic
- GARDP Neonatal Sepsis Trials: Funding for clinical trials and drug development for neonatal sepsis.
- Wellcome Trust Open Calls: Funding for infectious disease and AMR research, including sepsis.
- Bill & Melinda Gates Foundation: Global health grants, including sepsis and AMR.
Asia
- ICMR and NSFC: Regular calls for infectious disease and sepsis research.
4. Open Calls (as of May 2025):
- NIH SBIR/STTR for Sepsis Diagnostics and Therapeutics: NOT-GM-20-028 (open, check NIH Guide for deadlines)
- BARDA DRIVe: Current Active Programs (rolling submissions for diagnostics and therapeutics)
- AHRQ Large Research Grants (R01) and Demonstration Projects (R18): AHRQ HAI/Sepsis Funding (rolling submissions)
- Sepsis Research FEAT: Current Calls (check for 2025 deadlines)
- Horizon Europe: Open Calls (search for “sepsis” and “infectious diseases”)
- GARDP Neonatal Sepsis Trials: GARDP News (contact for current opportunities)
- Wellcome Trust: Open Funding Schemes (rolling and deadline-based calls)
5. Additional Context:
- Collaborative Consortia: Many large grants (e.g., Horizon Europe, NIH U-series) require or encourage multi-institutional and international collaboration.
- Small Business Innovation: NIH SBIR/STTR and BARDA DRIVe are key for startups and SMEs developing diagnostics or therapeutics for sepsis.
- Philanthropic Funding: Foundations like Gates and Wellcome often fund global health consortia, especially for AMR and neonatal sepsis.
- Regional Opportunities: National agencies in China, India, South Africa, and other countries have regular calls for infectious disease and sepsis research.
- Advocacy and Policy: The Global Sepsis Alliance and Sepsis Alliance play a major role in advocacy, awareness, and sometimes direct funding.
6. References:
- NIH Grants & Funding
- NIGMS Sepsis Priorities
- NIH Sepsis Funding Analysis
- AHRQ Sepsis
- BARDA DRIVe
- CDC Grants
- CDMRP Funding
- Sepsis Research FEAT
- Horizon Europe
- Global Sepsis Alliance
- GARDP
- Gates Foundation
- Wellcome Trust
- NSFC
- ICMR
- End Sepsis - Funding Directives
- Funding Opportunities: The ARDS, Pneumonia, and Sepsis Phenotyping Consortium
- NIGMS SBIR/STTR for Sepsis
- Wellcome Funding Opportunities
- GARDP Neonatal Sepsis Trials
If you need more details on a specific agency, opportunity, or region, let me know!